Brief: Cardiff Oncology Reports Third Quarter 2022 Results

Cardiff Oncology

03/11/2022 22:44

Nov 3 (Reuters) - Cardiff Oncology Inc  CRDF.O :
    * CARDIFF ONCOLOGY REPORTS THIRD QUARTER 2022 RESULTS AND
PROVIDES
BUSINESS UPDATES
    * QTRLY ROYALTY REVENUES $93000 VERSUS $86000
    * QTRLY LOSS PER SHARE $0.20
    * Q3 REVENUE VIEW $68200.00 -- REFINITIV IBES DATA
    * Q3 EARNINGS PER SHARE VIEW $-0.26 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nPn91Hs2Sa 
Further company coverage:  CRDF.O 
 ((Reuters.Briefs@thomsonreuters.com;))